Efficacy and safety of lurasidone in bipolar depression: results from two, double blind, placebo-controlled studies

被引：0
|
作者：
Loebel, A. [1 ]
Cucchiaro, J. [1 ]
Silva, R. [1 ]
Sarma, K. [1 ]
Kroger, H. [1 ]
Calabrese, J. [2 ]
Sachs, G. [3 ,4 ]
Grossman, F. [1 ]
Pikalov, A. [1 ]
机构：
[1] Sunov Pharmaceut Inc, Clin Dev, Ft Lee, NJ USA
[2] Case Western Reserve Univ, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA
[3] Massachusetts Gen Hosp, Bipolar Clin, Boston, MA 02114 USA
[4] Massachusetts Gen Hosp, Res Program, Boston, MA 02114 USA
来源：
BIPOLAR DISORDERS | 2014年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：131 / 132
页数：2
相关论文
共 50 条
  • [31] Safety and efficacy of tomoxetine for ADHD in two double-blind, placebo-controlled trials
    Allen, AJ
    Spencer, TJ
    Heiligenstein, JH
    Faries, DE
    Kelsey, DK
    Laws, HF
    Wernicke, J
    Kendrick, KL
    Michelson, D
    BIOLOGICAL PSYCHIATRY, 2001, 49 (08) : 32S - 33S
  • [32] Efficacy and Safety of Lamotrigine as Add-On Treatment to Lithium in Bipolar Depression: A Multicenter, Double-Blind, Placebo-Controlled Trial
    van der Loos, Marc L. M.
    Mulder, Paul G. H.
    Hartong, Erwin G. Th. M.
    Blom, Marc B. J.
    Vergouwen, Anton C.
    de Keyzer, Herman J. U. E. M.
    Notten, Peter J. H.
    Luteijn, Marijke L.
    Timmermans, Manuela A.
    Nolen, Willem A.
    JOURNAL OF CLINICAL PSYCHIATRY, 2009, 70 (02) : 223 - 231
  • [33] Lurasidone as Adjunctive Therapy With Lithium or Valproate for the Treatment of Bipolar I Depression: A Randomized, Double-Blind, Placebo-Controlled Study
    Loebel, Antony
    Cucchiaro, Josephine
    Silva, Robert
    Kroger, Hans
    Sarma, Kaushik
    Xu, Jane
    Calabrese, Joseph R.
    AMERICAN JOURNAL OF PSYCHIATRY, 2014, 171 (02): : 169 - 177
  • [34] Safety and Efficacy of Intravenous Ganaxolone in Severe Postpartum Depression: Results From a Double-Blind, Placebo-Controlled Phase 2 Study
    Gutierrez-Esteinou, Rolando
    Maximos, Bassem
    Riesenberg, Robert
    Johnson, Kimball A.
    Aimetti, Alex
    Lappalainen, Jaako
    Masuoka, Lorianne
    BIOLOGICAL PSYCHIATRY, 2019, 85 (10) : S181 - S182
  • [35] Improvement in anxiety symptoms in bipolar depression with quetiapine monotherapy: Results from two placebo-controlled studies
    Macfadden, W.
    Lydiard, R. B.
    Culpper, L.
    Raines, S.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S238 - S238
  • [36] Efficacy and safety of cenobamate as adjunctive therapy in patients with uncontrolled focal seizures: results from two double-blind, placebo-controlled, international studies
    Steinhoff, B. J.
    Sanchez-Alvarez, J.
    Majkowska-Zwolinska, B.
    Maciejowski, M.
    Villanueva, V.
    Brandt, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 60 - 60
  • [37] Efficacy and safety of lurasidone in adolescents and young adults with schizophrenia: Pooled analysis of double-blind, placebo-controlled 6-week studies
    Calisti, F.
    Costamagna, I.
    Hsu, J.
    Tocco, M.
    Pikalov, A.
    Goldman, R.
    EUROPEAN PSYCHIATRY, 2021, 64 : S166 - S166
  • [38] Double-blind, placebo-controlled study of quetiapine in bipolar I depression
    Macfadden, W
    Calabrese, J
    McCoy, R
    Minkwitz, M
    Wilson, E
    Mullen, J
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S299 - S299
  • [39] Quetiapine in bipolar I depression: double-blind, placebo-controlled study
    Macfadden, W
    Calabrese, JR
    Suppes, T
    McCoy, R
    Minkwitz, M
    Wilson, E
    Mullen, J
    ACTA PSYCHIATRICA SCANDINAVICA, 2004, 110 : 27 - 27
  • [40] Double-blind, placebo-controlled study of quietiapine in bipolar I depression
    Macfadden, W
    Calabrese, JR
    McCoy, R
    Minkwitz, M
    Wilson, E
    Mullen, J
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S157 - S157
12345